Invivyd (IVVD) Receivables - Net (2024 - 2026)
Invivyd's (IVVD) quarterly Receivables - Net came in at $11.2 million in Q2 2026, up 29.02% on a YoY basis from $8.7 million in Q2 2025, and down 19.38% quarter-over-quarter from $13.9 million in Q4 2025.
Analysis
Invivyd (IVVD) Receivables - Net (2024 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Receivables - Net for 3 consecutive years, with $11.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Net rose 29.02% year-over-year to $11.2 million; the trailing twelve-month figure through Jun 2026 stood at $11.2 million (up 29.02% YoY), and the FY2025 full-year result was $13.9 million, up 27.63% from the prior year.
- Receivables - Net eased to $11.2 million in Q2 2026 per IVVD's latest filing, from $13.9 million in the prior quarter.
- Across five years, Receivables - Net topped out at $13.9 million in Q4 2025 and bottomed at $2.9 million in Q2 2024.
- Historically, Receivables - Net has averaged $9.3 million across 3 years, with a median of $9.3 million in 2025.
- The widest YoY moves for Receivables - Net: up 199.93% in 2025, down 20.15% in 2025.
- Over 3 years, Receivables - Net stood at $10.9 million in 2024, then grew by 27.63% to $13.9 million in 2025, then declined by 19.38% to $11.2 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $11.2 million, $13.9 million, and $9.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.22 Mn |
| Dec 31, 2025 | 13.92 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 8.56 Mn |
| Dec 31, 2024 | 10.91 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 2.90 Mn |